New drug aims to ease breathing and boost survival in heart shock
Disease control
Not yet recruiting
This study tests if the drug istaroxime can help people with mild to moderate cardiogenic shock caused by acute heart failure. About 600 adults will receive either istaroxime or a placebo through an IV for 48 hours. Researchers will check if it improves breathing, blood pressure,…
Phase: PHASE2, PHASE3 • Sponsor: Seismic Pharmaceuticals Operations LLC • Aim: Disease control
Last updated May 17, 2026 15:34 UTC